organ transplants

The convergence of ethical concerns, regulatory shifts, and dwindling resources is driving a radical reimagining of preclinical drug testing. A Bay Area startup, R3 Bio, is proposing a solution that sounds like science fiction: “organ sacks” – essentially, headless, nonsentient bodies grown to serve as highly sophisticated testing platforms. This isn’t simply about replacing animals; … Read more